Results 161 to 170 of about 872,427 (309)
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT Hypercoagulability contributes to atherosclerosis (AS) progression in individuals suffering from rheumatoid arthritis (RA), and thromboelastography (TEG) is a valuable diagnostic tool. This hospital‐based cross‐sectional study assessed the clinical efficacy of TEG parameters in detecting hypercoagulability and subclinical AS by purposively ...
Qing‐Lin Zhang +6 more
wiley +1 more source
How do I Know That the Jerks I See Are Tics?
Movement Disorders Clinical Practice, EarlyView.Tics are prevalent hyperkinesias that are most often encountered in the context of a primary tic disorder, as in Tourette syndrome. Although their recognition is typically straightforward, they often share some phenomenological features with other jerky hyperkinesias and may be mislabeled as such.
Talyta Grippe +2 more
wiley +1 more source
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Med Research, EarlyView.ABSTRACT The immune microenvironment includes immune cells, cytokines, extracellular matrix, vesicles, etc. The interactions between these components form a unique local immune microecology. Although immunity serves as the defense against external pathogens, aberrant immune activation often contributes to disease development.
Guoqing Li +13 more
wiley +1 more source
The Journal of Pathology, EarlyView.Abstract Post‐COVID‐19 condition (PCC), also known as long COVID, is a complex multiple organ system condition that can develop and persist for months after acute COVID‐19. PCC encompasses a wide range of symptoms, resulting in heterogeneous clinical manifestations. These manifestations likely arise from diverse underlying pathophysiological mechanisms,
Larissa E Vlaming‐van Eijk +5 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT TAFRO (thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly) syndrome is a rare, life‐threatening inflammatory condition linked to infections, neoplasms, and idiopathic multicentric Castleman disease. Interleukin (IL)‐6 inhibitors are the primary treatment, but refractory cases require alternatives. This
Serena Palmeri +10 more
wiley +1 more source
Infection vulnerability in pregnant women with and without systemic lupus erythematosus. [PDF]
LupusKhogali HI +5 more
europepmc +1 more source
An Integrative Mechanistic Model of Type 1 IFN‐Mediated Inflammation in Systemic Lupus Erythematosus
CPT: Pharmacometrics &Systems Pharmacology, EarlyView.ABSTRACT Type I interferon (IFN1) pathway–targeting therapies represent a highly promising class of remedies for the treatment of systemic lupus erythematosus. However, the overall clinical benefit of these compounds is afflicted by marked variability.
Alina Volkova +7 more
wiley +1 more source